Research ArticleCancer

Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

See allHide authors and affiliations

Science Translational Medicine  23 Jan 2019:
Vol. 11, Issue 476, eaat9321
DOI: 10.1126/scitranslmed.aat9321

Article Information

vol. 11 no. 476

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication June 13, 2018
  • Accepted for publication December 22, 2018
  • .

Author Information

  1. Guillem Pascual-Pasto1,2,
  2. Miriam Bazan-Peregrino3,
  3. Nagore G. Olaciregui1,2,
  4. Camilo A. Restrepo-Perdomo4,
  5. Ana Mato-Berciano3,
  6. Daniela Ottaviani5,6,
  7. Klaus Weber7,
  8. Genoveva Correa1,2,
  9. Sonia Paco1,2,
  10. Monica Vila-Ubach1,2,
  11. Maria Cuadrado-Vilanova1,2,
  12. Helena Castillo-Ecija1,2,
  13. Gaia Botteri1,2,
  14. Laura Garcia-Gerique1,2,
  15. Helena Moreno-Gilabert1,2,
  16. Marta Gimenez-Alejandre3,
  17. Patricia Alonso-Lopez3,
  18. Marti Farrera-Sal3,
  19. Silvia Torres-Manjon8,
  20. Dolores Ramos-Lozano8,
  21. Rafael Moreno8,
  22. Isabelle Aerts5,6,
  23. François Doz5,9,
  24. Nathalie Cassoux5,9,10,
  25. Elodie Chapeaublanc5,6,
  26. Montserrat Torrebadell1,2,
  27. Monica Roldan1,4,
  28. Andrés König11,
  29. Mariona Suñol4,
  30. Joana Claverol1,12,
  31. Cinzia Lavarino1,2,
  32. Torres Carmen de1,2,*,
  33. Ligia Fu13,
  34. François Radvanyi5,6,
  35. Francis L. Munier14,
  36. Jaume Catalá-Mora15,
  37. Jaume Mora1,2,
  38. Ramón Alemany8,
  39. Manel Cascalló3,
  40. Guillermo L. Chantada1,2,16,17 and
  41. Angel M. Carcaboso1,2,
  1. 1Institut de Recerca Sant Joan de Deu, Barcelona 08950, Spain.
  2. 2Pediatric Hematology and Oncology, Hospital Sant Joan de Deu, Barcelona 08950, Spain.
  3. 3VCN Biosciences, Sant Cugat del Valles, Barcelona 08174, Spain.
  4. 4Pathology, Hospital Sant Joan de Deu, Barcelona 08950, Spain.
  5. 5Institut Curie, CNRS, UMR144, SIREDO Oncology Center, 75248 Paris, France.
  6. 6Institut Curie, PSL Research University, 75248 Paris, France.
  7. 7AnaPath GmbH, Oberbuchsiten 4625, Switzerland.
  8. 8Translational Research Laboratory, IDIBELL-Institut Catala d’Oncologia, 08908, L’Hospitalet de Llobregat, Barcelona, Spain.
  9. 9Paris Descartes University, 75006 Paris, France.
  10. 10Institut Curie, Ophthalmic Oncology, 75248 Paris, France.
  11. 11Vivotecnia Research S.L., Tres Cantos, Madrid 28760, Spain.
  12. 12Clinical Trials Unit, Hospital Sant Joan de Deu, Barcelona 08950, Spain.
  13. 13Pediatric Hematology-Oncology, Hospital Escuela Universitario, Tegucigalpa, Honduras.
  14. 14Hôpital Ophtalmique Jules-Gonin, Lausanne 133, Switzerland.
  15. 15Ophthalmology, Hospital Sant Joan de Deu, Barcelona 08950, Spain.
  16. 16Hospital de Pediatria JP Garrahan, Buenos Aires 1245, Argentina.
  17. 17CONICET, Buenos Aires 1245, Argentina.
  1. Corresponding author. Email: amontero{at}fsjd.org

Altmetric

Article usage

Article usage: January 2019 to August 2020

AbstractFullPdf
Jan 201923697841804
Feb 20191013731305
Mar 201973111779
Apr 20196796757
May 20195246139
Jun 20194333628
Jul 20193425051
Aug 20194703432
Sep 20194134518
Oct 20195024439
Nov 20193533650
Dec 20192562118
Jan 202013312842
Feb 202026349145
Mar 20208327104
Apr 20201269133
May 20202270113
Jun 2020221274
Jul 2020412457
Aug 202013813

Stay Connected to Science Translational Medicine

Navigate This Article